Mosaic ImmunoEngineering (CPMV) Other Non-Current Liabilities (2011 - 2023)
Mosaic ImmunoEngineering (CPMV) posted quarterly Other Non-Current Liabilities of $33900.0 for Q1 2023, down 67.34% year-over-year from $103800.0 in Q1 2022, and down 27.41% quarter-over-quarter from $46700.0 in Q4 2022.
Mosaic ImmunoEngineering (CPMV) Other Non-Current Liabilities (2011 - 2023) Analysis & Trends
Mosaic ImmunoEngineering's Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $33900.0 for Q1 2023.
- In Q1 2023, Other Non-Current Liabilities fell 67.34% year-over-year to $33900.0; the TTM figure through Mar 2023 stood at $33900.0 (down 67.34% YoY), while the FY2022 annual figure was $46700.0, down 55.23% from the prior year.
- Other Non-Current Liabilities for Q1 2023 stood at $33900.0, down from $46700.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $104300.0 in Q2 2021, with the low at $33900.0 in Q1 2023.
- The 4-year median for Other Non-Current Liabilities is $83500.0 (2020), against an average of $81554.5.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities gained 24.31% in 2022, then slumped 67.34% in 2023.
- Mosaic ImmunoEngineering's Other Non-Current Liabilities stood at $83500.0 in 2020, then advanced by 24.91% to $104300.0 in 2021, then slumped by 55.23% to $46700.0 in 2022, then retreated by 27.41% to $33900.0 in 2023.
- Business Quant data shows CPMV's Other Non-Current Liabilities at $33900.0 in Q1 2023, $46700.0 in Q4 2022, and $46300.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 33,900.00 |
| Dec 31, 2022 | 46,700.00 |
| Sep 30, 2022 | 46,300.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 103,800.00 |
| Dec 31, 2021 | 104,300.00 |
| Sep 30, 2021 | 104,300.00 |
| Jun 30, 2021 | 104,300.00 |
| Mar 31, 2021 | 83,500.00 |
| Nov 30, 2020 | 83,500.00 |
| Aug 31, 2020 | 83,500.00 |
| May 31, 2011 | 3,240.00 |